These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26773546)

  • 41. The effect of hepatitis C treatment response on medical costs: a longitudinal analysis in an integrated care setting.
    Manos MM; Darbinian J; Rubin J; Ray GT; Shvachko V; Denis B; Velez F; Quesenberry C
    J Manag Care Pharm; 2013; 19(6):438-47. PubMed ID: 23806057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hospital related morbidity from chronic hepatitis C virus (HCV) infection in Australia and mortality from HCV infection in a population cohort in Denmark: two complementary studies relevant to counseling patients.
    Shouval D
    J Hepatol; 2010 Jul; 53(1):1. PubMed ID: 20472320
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment patterns, health care resource utilization, and costs in U.S. patients diagnosed with chronic hepatitis C infection who received telaprevir or boceprevir.
    Le TK; Kalsekar A; Macaulay D; Yuan Y; Sorg RA; Behrer CR; Wei J; Wu EQ
    J Manag Care Spec Pharm; 2015 Apr; 21(4):308-18. PubMed ID: 25803764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study.
    Imazeki F; Yokosuka O; Fukai K; Saisho H
    Hepatology; 2003 Aug; 38(2):493-502. PubMed ID: 12883494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The growing contribution of hepatitis C virus infection to liver-related mortality in Scotland.
    McDonald SA; Hutchinson SJ; Bird SM; Robertson C; Mills PR; Graham L; Dillon JF; Goldberg DJ
    Euro Surveill; 2010 May; 15(18):. PubMed ID: 20460092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population.
    El-Kamary SS; Jhaveri R; Shardell MD
    Clin Infect Dis; 2011 Jul; 53(2):150-7. PubMed ID: 21665867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies.
    Hamadeh A; Haines A; Feng Z; Thein HH; Janjua NZ; Krahn M; Wong WWL
    J Viral Hepat; 2020 Dec; 27(12):1419-1429. PubMed ID: 32810886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.
    Christensen PB; Hay G; Jepsen P; Omland LH; Just SA; Krarup HB; Weis N; Obel N; Cowan S
    BMC Infect Dis; 2012 Aug; 12():178. PubMed ID: 22866925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential evolution of mortality between Denmark and Scotland, period 1970 to 1999. A comparison with mortality data from the European Union.
    Kesteloot H
    Eur J Epidemiol; 2006; 21(1):3-13. PubMed ID: 16450201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991-2006.
    McDonald SA; Hutchinson SJ; Bird SM; Mills PR; Hayes P; Dillon JF; Goldberg DJ
    Epidemiol Infect; 2011 Mar; 139(3):344-53. PubMed ID: 20587118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geographic variation in diagnostic and treatment interval, cancer stage and mortality among colorectal patients - An international comparison between Denmark and Scotland using data-linked cohorts.
    Murchie P; Falborg AZ; Turner M; Vedsted P; Virgilsen LF
    Cancer Epidemiol; 2021 Oct; 74():102004. PubMed ID: 34419802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial commentary: Determining the effect of hepatitis C on mortality: sorting the signal from the noise.
    Rose KM
    Clin Infect Dis; 2014 Apr; 58(8):1062-3. PubMed ID: 24523216
    [No Abstract]   [Full Text] [Related]  

  • 54. Danish multidisciplinary cancer groups - DMCG.dk benchmarking consortium: Article series on cancer survival and mortality in Denmark 1995-2012.
    Nguyen-Nielsen M; Borre M
    Acta Oncol; 2016 Jun; 55 Suppl 2():1. PubMed ID: 27355391
    [No Abstract]   [Full Text] [Related]  

  • 55. Socioeconomic factors and determinants of mortality.
    Smith GD; Hart C
    JAMA; 1998 Nov; 280(20):1744-5. PubMed ID: 9842945
    [No Abstract]   [Full Text] [Related]  

  • 56. Medico-statistical information from Denmark for the years 1959 and 1960.
    DREYER K; FRANDSEN E; HAMTOFT H
    Dan Med Bull; 1961 Dec; 8():171-6. PubMed ID: 13887835
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the specific mortality rates in town and country districts of Scotland since 1871.
    Barclay RS; Kermack WO; McKendrick AG
    J Hyg (Lond); 1940 Jul; 40(4):423-33. PubMed ID: 20475552
    [No Abstract]   [Full Text] [Related]  

  • 58. Mortality from Cancer According to Site in the Counties of Scotland, 1923-8.
    Russell WT
    J Hyg (Lond); 1931 Oct; 31(4):563-9. PubMed ID: 20475115
    [No Abstract]   [Full Text] [Related]  

  • 59. Methods for producing a national infection prevention and control manual (NIPCM) in Scotland.
    Ritchie L; Boswell C; McIntyre J; Macdonald L
    Infect Prev Pract; 2020 Jun; 2(2):100058. PubMed ID: 34316557
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatitis C reinfection after sustained virological response.
    Midgard H; Bjøro B; Mæland A; Konopski Z; Kileng H; Damås JK; Paulsen J; Heggelund L; Sandvei PK; Ringstad JO; Karlsen LN; Stene-Johansen K; Pettersson JH; Dorenberg DH; Dalgard O
    J Hepatol; 2016 May; 64(5):1020-1026. PubMed ID: 26780289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.